Aimovig

• Brands Aimovig
• Product Code: Aimovig

• Aimovig (erenumab-aooe) is a monoclonal antibody used for the preventive treatment of migraines in adults. It is the first FDA-approved drug in its class to target and block the calcitonin gene-related peptide (CGRP) receptor, which plays a critical role in migraine development.

  By inhibiting the CGRP receptor, Aimovig helps prevent migraine attacks before they start, reducing their frequency, duration, and severity.

  How it's used:

  • Given as a once-monthly subcutaneous injection

  • Available in 70 mg or 140 mg doses, using a prefilled autoinjector or syringe

  Who it's for:

  • Adults with episodic or chronic migraine

  • Not used to treat acute migraine attacks (not a pain reliever)

  Common side effects:

  • Injection site reactions

  • Constipation

  • Muscle cramps or spasms

  Rare but serious risks:

  • Hypersensitivity reactions (rash, swelling)

  • Worsening of constipation in some patients

  Aimovig may be particularly helpful for those who haven't responded well to oral migraine preventives (like beta-blockers, antiepileptics, or antidepressants).

• Availability: In Stock

• American Diabetes Association

• Diabetes Disaster_Response Coalition storing insulin

• FDA Approved Prescription